Althammer F, Roy RK, Lefevre A, Najjar RS, Schoenig K, Bartsch D, Eliava M, Feresin RG, Hammock EAD, Murphy AZ, Charlet A, Grinevich V, Stern JE. Altered PVN-to-CA2 hippocampal oxytocin pathway and reduced number of oxytocin-receptor expressing astrocytes in heart failure rats. J Neuroendocrinol. 2022 34(7):e13166. Epub 2022 Jun 3.
Althammer F, Wimmer MC, Krabichler Q, Küppers S, Schimmer J, Fröhlich H, Dötsch L, Gruber T, Wunsch S, Schubert T, Kirchner MK, Stern JE, Charlet A, Grinevich V, Schaaf CP. Analysis of the hypothalamic oxytocin system and oxytocin receptor-expressing astrocytes in a mouse model of Prader-Willi syndrome. J Neuroendocrinol. 2022 34(12):e13217. Epub 2022 Dec 1.
Holmes J, Lau T, Saylor R, Fernández-Novel N, Hersey M, Keen D, Hampel L, Horschitz S, Ladewig J, Parke B, Reed MC, Nijhout HF, Best J, Koch P, Hashemi P. Voltammetric Approach for Characterizing the Biophysical and Chemical Functionality of Human Induced Pluripotent Stem Cell-Derived Serotonin Neurons. Anal Chem. 2022 94(25):8847-8856.
Mallien A, Becker L, Pfeiffer N, Terraneo F, Hahn M, Middelman A, Palme R, Creutzberg KC, Begni V, Riva MA, Leo D, Potschka H, Fumagalli F, Homberg JR, Gass P. Dopamine Transporter Knockout Rats Show Impaired Wellbeing in a Multimodal Severity Assessment Approach. Front Behav Neurosci. 2022 16:924603.
Mallien A, Pfeiffer N, Brandwein C, Inta D, Sprengel R, Palme R, Talbot SR, Gass P. Comparative Severity Assessment of Genetic, Stress-Based, and Pharmacological Mouse Models of Depression. Front Behav Neurosci. 2022 16:908366.
Oberländer K, Witte V, Mallien A, Gass P, Bengtson CP, Bading H. Dysregulation of and expression and an altered excitation-inhibition balance are associated with cognitive deficits in DBA/2 mice. Learn Mem. 2022 29(2):55-70.
Reinwald J, Gass N, Mallien A, Sartorius A, Becker R, Sack MS, Falfán-Melgoza C, Clemm von Hohenberg C, Leo D, Pfeiffer N, Middelman A, Meyer-Lindenberg A, Homberg JR, Weber-Fahr W, Gass P. Dopamine transporter silencing in the rat: systems-level alterations in striato-cerebellar and prefrontal-midbrain circuits. Mol Psychiatry. 2022 27(4):2329-2339. Epub 2022 Mar 4.
Vasilescu AN, Pfeiffer N, Terraneo F, Riva MA, Lang UE, Inta D, Gass P. Region-specific enhancement of c-fos expression by combined treatment with NMDA receptor agonists and antagonists with antidepressant potential. Int J Neuropsychopharmacol. 2022 48(6):1273-1283. Epub 2022 Aug 17.